Special Communications
Notifications outline changes to testing, supplies, and other updates.
Routine test changes are provided to clients in the monthly Technical Update.
For urgent updates, please refer to Immediate Test Changes. If you have any questions about the information listed here, please contact Client Services.
September 27, 2023
September 2023: Changes to Reference Ranges – Catecholamines, Fractionated, Plasma (PLCAT)
December 1, 2022
December 2022: Changes to Acceptable Tube Type for Azole Anti-Fungal Therapeutic Drug Monitoring
May 13, 2022
May 2022: Immediate Test Discontinuation – Giardia lamblia IgG, IgA, IgM (GIAGAM)
March 2, 2022
March 2022: Changes to CBCDIF Result Reporting; Aldosterone Reference Intervals
February 28, 2022
February 2022: Immediate Test Discontinuation – Digoxin, Free, Serum (DIGFR)
January 17, 2022
January 2022: Changes to Specimen Requirements, Reference Ranges, and More
December 14, 2021
December 2021: Test Delay – HIV-1 Antibody Confirmation by Western Blot (HIV1CO)
July 22, 2021
August 2021: Changes to Specimen Requirements, Reference Ranges, and Test Builds
July 13, 2021
July 2021: Test Menu Optimization & Discontinuations – MGLESE, MYSGRV, PARSYN
July 1, 2021
July 2021: Immediate Test Discontinuation – Hepatitis A Antibody, Total (AHAVT)
November 13, 2020
November 2020: Temporarily Unavailable – Stool Gastrointestinal Panel by PCR
October 16, 2020
COVID-19: Supply Constraints Affecting Enteric Bacterial Panel by PCR Testing
September 16, 2020
COVID-19: Supply Shortages Impacting Gonorrhea, Chlamydia, and Trichomoniasis Testing
August 19, 2020
August 2020: Update – Cytogenetic Karyotyping & Chromosomal Microarray Testing
October 24, 2019
October 2019: Changes to Specimen Requirements, Reference Ranges, and Test Builds
September 3, 2019
September 2019: Updates to Testosterone, Free & Total, Testing and Reporting